Protein is the most satiating macronutrient and can help bridge the gap until semaglutide's appetite suppression kicks in
NHS patient information describes semaglutide as being used for obesity under the Wegovy brand and for type 2 diabetes under Ozempic and Rybelsus
Cardiometabolic benefits Both tirzepatide and retatrutide have demonstrated improvements in various cardiometabolic risk factors, such as blood pressure, lipid profiles, and glycemic control
Meals are portion-controlled with higher protein content, and Factor includes a free 20-minute dietitian coaching session
Clinical trials and FDA labeling show eructation or burping occurs in approximately 3% of people taking Ozempic injection, up to 2% in people taking Rybelsus (rebranded to Ozempic pill), about 7% of those on Wegovy, and 25% with Mounjaro and Zepbound
It mainly works in the hormonal and brain systems